Related Experiment Video
Updated: Mar 15, 2026
09:30
Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
4.6K
Pharmaceutical Approval Update
P & T : a Peer-Reviewed Journal for Formulary Management
|September 16, 2016
Abstract:
Cabozantinib (Cabometyx) for advanced renal cell carcinoma; glycopyrrolate/formoterol fumarate (Bevespi Aerosphere) for chronic obstructive pulmonary disease; and ephedrine sulfate (Akovaz) for hypotension during anesthesia.
Insights
New drug approvals include Cabozantinib for advanced renal cell carcinoma, Bevespi Aerosphere for COPD, and Akovaz for hypotension during anesthesia. These treatments offer new options for patients with these serious conditions.
Area of Science:
- Oncology
- Pulmonology
- Anesthesiology
Background:
- Advanced renal cell carcinoma (RCC) presents significant treatment challenges.
- Chronic obstructive pulmonary disease (COPD) requires effective long-term management strategies.
- Hypotension during anesthesia can lead to serious complications.
Purpose of the Study:
- To review the efficacy and safety of newly approved medications for specific medical conditions.
- To provide an overview of therapeutic advancements in oncology, pulmonology, and anesthesiology.
- To inform healthcare professionals about novel treatment options.
Main Methods:
- Review of clinical trial data and regulatory submissions for new drug approvals.
- Analysis of pharmacokinetic and pharmacodynamic profiles.
- Evaluation of safety and tolerability data.
Main Results:
- Cabozantinib (Cabometyx) demonstrated efficacy in advanced renal cell carcinoma.
- Glycopyrrolate/formoterol fumarate (Bevespi Aerosphere) showed benefits in managing COPD symptoms.
- Ephedrine sulfate (Akovaz) proved effective in treating hypotension during anesthesia.
Conclusions:
- Cabozantinib, Bevespi Aerosphere, and Akovaz represent significant therapeutic advancements.
- These new approvals offer valuable additions to the clinical armamentarium for treating RCC, COPD, and anesthesia-induced hypotension.
- Further research and real-world data will continue to define the role of these agents.
Related Concept Videos
01:26FDA Approved Drugs: Changes to Approved Drugs
313
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
313
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
59
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
59
01:25Drug Regulation
3.2K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.2K
01:26Drug Administration and Therapy Phases: Overview
1.6K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.6K
01:28Drug Products: Biologics, Biosimilars and Interchangeables
336
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
336
01:02Prescription, Nonprescription and Orphan Drugs
1.4K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.4K